Rights and permissions
About this article
Cite this article
Natalizumab: `positive efficacy trend' in Crohn's disease. Inpharma Wkly. 1304, 9 (2001). https://doi.org/10.2165/00128413-200113040-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200113040-00019